Results 1 to 10 of about 81,436 (246)
Co-relation of coagulation profile with glycemic index in patients with type 2 diabetes [PDF]
Journal of Family Medicine and Primary CareBackground: Diabetes mellitus (DM) has emerged as a significant global concern that accounts for nearly 90% of type 2 DM cases worldwide and characterized by insulin resistance. Hyperglycemia in diabetes leads to increased fibrinogen levels and activates
Sushil Kumar +5 more
doaj +2 more sources
The Thromboplastin Generation Test [PDF]
Journal of Clinical Pathology, 1953 Physiological coagulation is dependent on the formation of a powerful thromboplastin within the blood.
A. S. Douglas, Rosemary Biggs
openaire +4 more sources
The Varied Sensitivity of Partial Thromboplastin and Prothrombin Time Reagents in the Demonstration of the Lupus‐Like Anticoagulant [PDF]
Scandinavian Journal of Haematology, 1979 An acquired inhibitor of blood coagulation, similar to that described in patients with Systemic Lupus Erythematosus (SLE), was detected during routine coagulation screening in 10 patients who did not meet the criteria for a diagnosis of SLE.
P.M. Mannucci +3 more
openalex +2 more sources
A Novel Thromboplastin-Based Rat Model of Ischemic Stroke
Brain Sciences, 2021 The thromboembolic ischemia model is one of the most applicable for studying ischemic stroke in humans. The aim of this study was to develop a novel thromboembolic stroke model, allowing, by affordable tools, to reproduce cerebral infarction in rats.
Irina V. Ostrova +3 more
doaj +1 more source
The role of hemostatic changes in the pathogenesis of diabetic retinopathy
Journal of Education, Health and Sport, 2022 Introduction: The paper presents the results of the hemostasis system of rats with experimental diabetic retinopathy. Material and methods: Experimental studies were performed on white Wistar rats, which were divided into 2 groups: 1st group – intact
Nataliya Preys, Ivan Savytskyi
doaj +1 more source
Thromboplastin Bilbao: Reproducibility and Sensitivity of a Spanish Thromboplastin [PDF]
Pathophysiology of Haemostasis and Thrombosis, 2002 Prothrombin time (PT) is the control test for oral anticoagulant therapy as well as the screening test for defects of the extrinsic pathway of coagulation. Its responsiveness to decreased extrinsic clotting factors depends on the source and type of tissue factor thromboplastin extract. In 1994, a rabbit brain thromboplastin – Thromboplastin Bilbao (TBi)
I. Unanue +4 more
openaire +3 more sources
Frontiers in Neurology, 2020 Background: Lupus anticoagulant (LA) owns procoagulant properties in vivo and prolongs phospholipid-dependent clotting times in vitro. The prolonged in vitro clotting time can be misinterpreted as a bleeding disorder.
Aydin Huseynov +10 more
doaj +1 more source
UMYU Journal of Microbiology Research, 2021 Coronavirus disease 2019 (COVID-19) is associated with coagulation abnormalities- disordered hemostasis and high thrombotic risk. The aim of the study was to compare and analyze the clotting profiles between COVID-19 and non-COVID-19 patients in Barau ...
Abdulfatai K +5 more
doaj +1 more source
An Evaluation of the Activated Partial Thromboplastin Time Waveform
Clinical and applied thrombosis/hemostasis, 2018 The activated partial thromboplastin time (APTT) waveform includes several parameters that are related to various underlying diseases. The APTT waveform was examined in various diseases.
Takeshi Matsumoto +12 more
semanticscholar +1 more source